mRNA技術は、新型コロナウイルス感染症（COVID-19）ワクチンを含む多くの病気に応用されています。mRNAの市場は、癌治療での主な用途に加えて、主にCovid-19ワクチンによって推進されています。コロナウイルスの変異とウイルスの変異体の拡散の可能性により、mRNA企業はCovid-19の次世代ワクチンの開発に積極的に取り組んでいます。
2025年の世界のmRNAワクチンおよび治療薬市場は、296億7,231万USドルと推定されています。糖尿病、HIV、癌、CVDなどの慢性疾患や感染症の増加は、市場の成長を促す大きな要因の一つです。また、エボラ出血熱、インフルエンザ、ヒト免疫不全ウイルス（HIV）などのウイルス感染症に対する治療薬やワクチンの需要が高まっていることや、従来のワクチンアプローチでは重要な時期にワクチンを見つけることができないことも、市場の成長を後押ししています。
従来の医薬品と比較して、mRNAワクチンおよび治療薬は、病原体に対してより効果的で、より高い効果を持ち、免疫原性を改善し、製造に必要なコストが少ない高度な技術の助けを借りて開発されています。
mRNAワクチンおよび治療薬市場では、Covid-19ワクチンが最大のシェアを占めると予想されています。2026年から2030年の予測期間中の癌治療セグメントの標準化は、市場成長に最も貢献すると予想されています。その主な理由は、世界中で癌患者の数が増加し、その治療のための一連の基準を持つことが不可欠になっているからです。
北アメリカは、革新的な治療法を開発する必要性の高まり、資金注入の増加、良好な規制環境、プレシジョン・メディシン（精密医療）の確立への注目度の高まりなどにより、非Covid-19ワクチンのmRNAワクチンおよび治療薬市場で最大のシェアを占めています。アジア地域の発展途上経済における癌および他の疾患の有病率の上昇は、APAC地域におけるmRNAワクチンおよび治療薬の需要を増大させています。
目次
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2.Strategic Recommendations
3. mRNA Vaccine and Therapeutics Market: Product Outlook
4. Global mRNA Vaccine and Therapeutics Market: Sizing and Forecast
4.1 Global mRNA Vaccine and Therapeutics Market Size, By Value, Year 2021-2030
5.Global mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User
5.1 Competitive Scenario of Global mRNA Vaccine and Therapeutics Market: By Product
5.1.1 COVID Vaccines - Market Size and Forecast (2021-2030)
5.1.2 Infectious Disease Vaccines - Market Size and Forecast (2021-2030)
5.1.3 Cancer Vaccines - Market Size and Forecast (2021-2030)
5.1.4 Autoimmune Diseases - Market Size and Forecast (2021-2030)
5.1.5 Others - Market Size and Forecast (2021-2030)
5.2 Competitive Scenario of Global mRNA Vaccine and Therapeutics Market: By End User
5.2.1 Hospitals & Clinics - Market Size and Forecast (2021-2030)
5.2.2 Research & Organizations - Market Size and Forecast (2021-2030)
5.2.3 Others - Market Size and Forecast (2021-2030)
6. Global mRNA Vaccine and Therapeutics Market: Regional Analysis
6.1 Competitive Scenario of Global mRNA Vaccine and Therapeutics Market: By Region
7.North America mRNA Vaccine and Therapeutics Market : An Analysis (2021-2030)
7.1 North America mRNA Vaccine and Therapeutics Market : Size and Forecast (2021-2030), By Value
7.2 North America mRNA Vaccine and Therapeutics Market - Prominent Companies
7.3 Market Segmentation By Product (COVID Vaccines, Infectious Disease Vaccines, Cancer Vaccines, Autoimmune Diseases, Others)
7.4 Market Segmentation End User (Hospitals & Clinics, Research & Organizations, Others)
7.5 North America mRNA Vaccine and Therapeutics Market: Country Analysis
7.6 Market Opportunity Chart of North America mRNA Vaccine and Therapeutics Market - By Country, By Value, 2030
7.7 Competitive Scenario of North America mRNA Vaccine and Therapeutics Market: By Country
7.8 United States mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
7.9 United States mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User (2021-2030)
7.10 Canada mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
7.11 Canada mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User (2021-2030)
8. Europe mRNA Vaccine and Therapeutics Market : An Analysis (2021-2030)
8.1 Europe mRNA Vaccine and Therapeutics Market : Size and Forecast (2021-2030), By Value
8.2 Europe mRNA Vaccine and Therapeutics Market - Prominent Companies
8.3 Market Segmentation By Product (COVID Vaccines, Infectious Disease Vaccines, Cancer Vaccines, Autoimmune Diseases, Others)
8.4 Market Segmentation End User (Hospitals & Clinics, Research & Organizations, Others )
8.5 Europe mRNA Vaccine and Therapeutics Market: Country Analysis
8.6 Market Opportunity Chart of Europe mRNA Vaccine and Therapeutics Market - By Country, By Value, 2030
8.7 Competitive Scenario of North America mRNA Vaccine and Therapeutics Market: By Country
8.8 Germany mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
8.9 Germany mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User (2021-2030)
8.10 United Kingdom mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
8.11 United Kingdom mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User (2021-2030)
8.12 France mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
8.13 France mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User (2021-2030)
8.14 Switzerland mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
8.15 Switzerland mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User (2021-2030)
8.16 Russia mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
8.17 Russia mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User (2021-2030)
9.Asia Pacific mRNA Vaccine and Therapeutics Market : An Analysis (2021-2030)
9.1 Asia Pacific mRNA Vaccine and Therapeutics Market : Size and Forecast (2021-2030), By Value
9.2 Asia Pacific mRNA Vaccine and Therapeutics Market - Prominent Companies
9.3 Market Segmentation By Product (COVID Vaccines, Infectious Disease Vaccines, Cancer Vaccines, Autoimmune Diseases, Others)
9.4 Market Segmentation End User (Hospitals & Clinics, Research & Organizations, Others )
9.5 Asia Pacific mRNA Vaccine and Therapeutics Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific mRNA Vaccine and Therapeutics Market - By Country, By Value, 2030
9.7 Competitive Scenario of Asia Pacific mRNA Vaccine and Therapeutics Market: By Country
9.8 China mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
9.9 China mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User (2021-2030)
9.10 Japan mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
9.11 Japan mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User (2021-2030)
9.12 India mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
9.13 India mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User (2021-2030)
10.Global mRNA Vaccine and Therapeutics Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11.Market Attractiveness
11.1 Market Attractiveness Chart of Global mRNA Vaccine and Therapeutics Market - By Product, 2030
11.2 Market Attractiveness Chart of Global mRNA Vaccine and Therapeutics Market - By End User, 2030
11.3 Market Attractiveness Chart of Global mRNA Vaccine and Therapeutics Market - By Region, 2030
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
13.mRNA Vaccine and Therapeutics Pipeline Development
13.1 mRNA vaccine development pipeline for infectious diseases
13.2 mRNA cancer therapies in development
13.3 mRNA-based protein therapeutics in development
14. Regulatory Compliance
15. Company Analysis
15.1 AstraZeneca Plc
15.2 Bayer Group
15.3 Boehringer Ingelheim
15.4 GlaxoSmithKline
15.5 Pfizer
15.6 Moderna
15.7 BioNtech
15.8 Sangamo Therapeutics
15.9 Crispr Therapeutics
15.10 Intellia Therapeutics
